Author:
Bavi P,Jehan Z,Bu R,Prabhakaran S,Al-Sanea N,Al-Dayel F,Al-Assiri M,Al-Halouly T,Sairafi R,Uddin S,Al-Kuraya K S
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Abubaker J, Bavi P, Al-Haqawi W, Sultana M, Al-Harbi S, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Uddin S, Al-Kuraya KS (2009) Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma. J Pathol 219: 435–445.
2. Abubaker J, Jehan Z, Bavi P, Sultana M, Al-Harbi S, Ibrahim M, Al-Nuaim A, Ahmed M, Amin T, Al-Fehaily M, Al-Sanea O, Al-Dayel F, Uddin S, Al-Kuraya KS (2008) Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population. J Clin Endocrinol Metab 93: 611–618.
3. Adjei AA (2001) Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 93: 1062–1074.
4. Al-Eid HS, Manalo MS (2007) Saudi Cancer Registry. Saudi Arabia Cancer Incidence and Survival Report 2007, A-ZA Bazarbashi S (ed.) King Faisal Specialist Hospital & Research Centre: Riyadh, Saudi Arabia.
5. Armstrong F, Lamant L, Hieblot C, Delsol G, Touriol C (2007) TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins. Eur J Cancer 43: 640–646.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献